Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

Bochner, F.; Lloyd, J.

doi:10.1042/cs0710625

Skip Nav Destination

Article navigation

Other| December 01 1986

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

F. Bochner;

F. Bochner

¹Department of Clinical and Experimental Pharmacology, University of Adelaide, and Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia

Search for other works by this author on:

This Site

PubMed

Google Scholar

J. Lloyd

²Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1986) 71 (6): 625–631.

https://doi.org/10.1042/cs0710625

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only